Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2008
10/02/2008WO2008116860A2 Dsrna compositions and methods for treating hpv infections
10/02/2008WO2008116819A1 Method for producing a transformed cell
10/02/2008WO2008116380A1 A vaccine preventing and/or treating autoimmune diseases
10/02/2008WO2008116316A1 Vector encoding therapeutic polypeptide and safety elements to clear transduced cells
10/02/2008WO2008116267A1 Therapeutic targets and molecules
10/02/2008WO2008084254A3 Cell line for alzheimer's disease therapy screening
10/02/2008WO2008021140A3 Recombinant aav production in mammalian cells
10/02/2008WO2008011133A3 Compositions of late passage mesenchymal stem cells (mscs)
10/02/2008WO2007092182A3 Rna interference agents for therapeutic use
10/02/2008US20080242637 Binding efficiency;cyxicity; therapy for lung, colon, ovariers tumor
10/02/2008US20080242629 Hybrid nucleic acids; controlling gene expression; metabolism disorders, obesity, diabetes
10/02/2008US20080242628 In vivo
10/02/2008US20080242602 Methods and Compositions For the Inhibition of Hiv-1 Replication
10/02/2008US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same
10/02/2008US20080241946 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders
10/02/2008US20080241906 Shifting elution properties of viral protein in order to enhanced purification from solution
10/02/2008US20080241905 Retroviral vector comprising nucleotide sequences coding collagen domain for use in wound healing; tissue repair and engineering; regenerative medicine
10/02/2008US20080241882 Nucleotide sequences coding cell growth factor for use in diagnosis, prevention and treatment of nervous system disorders
10/02/2008US20080241857 Netrin receptors
10/02/2008US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
10/02/2008US20080241207 Culture medium; antibodies; bioassays; drug screening; administering with an agonist or antagonist; stromal cells; implants
10/02/2008US20080241196 Invasin complex comprising lipopolysaccharide component from gramnegative bacteria for use as tool to facilitate transport of biomolecules, therapeutics and antibiotics across cell membranes
10/02/2008US20080241194 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
10/02/2008US20080241186 Nucleic acid vaccines for prevention of flavivirus infection
10/02/2008US20080241175 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
10/02/2008US20080241162 Hepatitis c viral E2 glycoprotein specific immunoglobulin for use in prevention and treatment of hepatitis infection
10/02/2008US20080241153 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241152 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241147 Using pleckstrin homology (PH) domain-interacting protein as tool in detection and identification of modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241131 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders
10/02/2008US20080241116 Using vector comprising nucleotide sequences coding serine phage intergrase to transfer heterologous nucleotide sequences into cells; inproving exogenous gene expression; gene therapy
10/02/2008US20080241109 Using multimeric death receptor ligand as tumor targeting agent in treatment of cell proliferative disorders
10/02/2008US20080241105 Pretreatment with oncolytic virus
10/02/2008US20080241103 Recombinant Virus Comprising an Intact Tumor-Therapeutic Antibody With Human Constant Regions and the Use Thereof
10/02/2008US20080241097 Methods of treating neurological conditions with hematopoeitic growth factors
10/02/2008US20080241067 co-culturing cancer cells and host cells for a time sufficient to detect evidence of gene expression in co-culture for simulating the progression from a primary tumor to a metastasis in an in vitro model; anti-EphA2 ( epithelial cell kinase) antibody
10/02/2008US20080241064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
10/02/2008CA2719711A1 Vector encoding therapeutic polypeptide and safety elements to clear transduced cells
10/02/2008CA2682490A1 Prompt nucleic acid delivery carrier composition
10/02/2008CA2681775A1 A vaccine preventing and/or treating autoimmune diseases
10/02/2008CA2680837A1 Mek ligands and polynucleotides encoding mek ligands
10/02/2008CA2680832A1 Method for detecting autoprocessed, secreted pcsk9
10/01/2008EP1975239A1 Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high-throughput screening
10/01/2008EP1975234A2 Therapeutic and diagnotics agents capable of modulating cellular responsiveness to cytokines
10/01/2008EP1975233A1 Nucleic acid binding proteins
10/01/2008EP1974752A1 Subcellular targeting of therapeutic proteins
10/01/2008EP1974748A2 Antibodies for the diagnosis of diseases associated with fibrosis
10/01/2008EP1974738A2 Diagnostics and therapeutics for glaucoma
10/01/2008EP1974026A2 Mutant deoxyadenosine kinase enzymes and their use
10/01/2008EP1974012A2 Methods of improving stem cell homing and engraftment
10/01/2008EP1973574A2 Use of inhibitors of scinderin and/or of ephrin-a1 for treating tumors
10/01/2008EP1664314B1 Improved adeno-associated virus (aav) vector for gene therapy
10/01/2008EP1285080B1 Method for the purification of alphavirus replicon particles
10/01/2008EP1142590B1 Gene therapy for diabetic ischemic disease
10/01/2008EP1135113B1 Treatment of parkinson's disease with oligonucleotides
10/01/2008EP0766512B1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
10/01/2008CN101277722A Composition and method for prevention and treatment of type I diabetes
10/01/2008CN101275142A Newcastle disease virus infectious clones, vaccines and diagnostic assays
10/01/2008CN101275140A Cysticercosis cellulosae recombination gene, vaccin and preparation thereof
10/01/2008CN101275136A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and DNAs encoding the same
10/01/2008CN101275135A Antisense oligonucleotide for tissue-specific regulation of POKEMON gene expression and application thereof
10/01/2008CN101275134A Medicament for curing breast carcinoma and special antisense oligonucleotide therefor
10/01/2008CN101275133A DNA sequence of IER5-coded SiRNA, vector and application thereof
10/01/2008CN101275132A SiRNA capable of inhibiting influenza A virus replication and coding sequence thereof
10/01/2008CN100422343C Method of distinguishing drug-resistance of hepatitis b virus
10/01/2008CN100422332C Expression and export of angiostation and endostatin as immunofusins
10/01/2008CN100422326C Si RNA capable of controlling foot-and-mouth disease virus copying and infection and its preparing method and use
10/01/2008CN100422322C Foot and mouth disease virus vaccine
10/01/2008CN100422315C Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
10/01/2008CN100422212C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
10/01/2008CN100421727C Methods
10/01/2008CA2654894A1 Csf3r polypeptides and uses thereof
09/2008
09/30/2008US7429656 Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference
09/30/2008US7429648 IREN protein, its preparation and use
09/30/2008US7429643 POSH nucleic acids, polypeptides and related methods
09/30/2008US7429489 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine
09/30/2008US7429467 Solution comprising surfactant, hydrophobic phase and hydrophilic phase comprising plurality of microcapsules containing functional in vitro eukaryotic expression system for transfer of heterologous into cells
09/30/2008US7429461 Genetic products differentially expressed in tumors and use thereof
09/30/2008US7429459 for identifying compounds that inhibit amyloidal-beta precursor protein processing in cells, comprising contacting a test compound with a GPCR polypeptide, or fragment thereof, and measuring a compound-GPCR property related to the production of amyloidal-beta peptide.
09/30/2008US7429376 Methods of screening for compounds that improve engraftment
09/30/2008CA2309766C Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
09/30/2008CA2261989C Recombinant pox virus for immunization against tumor-associated antigens
09/30/2008CA2261987C Vectors for inhibiting hiv and tumor growth
09/27/2008CA2584494A1 Vector encoding therapeutic polypeptide and safety elements to clear transduced cells
09/25/2008WO2008116220A2 Methods and compositions related to riboswitches that control alternative splicing
09/25/2008WO2008116111A2 Growth factor mediated cosmeceuticals and use thereof to enhance skin quality
09/25/2008WO2008116094A2 Combined hairpin-antisense compositions and methods for modulating expression
09/25/2008WO2008116032A1 Compositions and methods for inhibiting tumor cell growth
09/25/2008WO2008115959A1 Hypoxia inducible factor inducer and methods for using the same
09/25/2008WO2008115799A1 Novel gene delivery vectors for human mesenchymal stem cells
09/25/2008WO2008114889A1 Oral vaccine
09/25/2008WO2008114876A1 A method of treating malignant mesothelioma
09/25/2008WO2008114856A1 Method for of transcription-degradation dual regulation for protein by antibiotic
09/25/2008WO2008114787A1 Antiviral agent
09/25/2008WO2008114262A2 Oligoribonucleotide inhibitors of nrf2 and methods of use thereof for treatment of cancer
09/25/2008WO2008113983A2 Cancer cell specific promoter comprising nf-kappa b binding sites
09/25/2008WO2008113606A1 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use
09/25/2008WO2008089003A3 System for optical stimulation of target cells
09/25/2008WO2008084319A3 Novel nucleic acid
09/25/2008WO2008083949A3 Rna-coded antibody
1 ... 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 ... 870